Shockwave therapy to improve arm function after stroke
Tests shockwave therapy for arm stiffness and weakness in adults after a stroke.
Plain-language title generated from the registry record
Registry title: Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke.
Key facts
- Where
- Ajman, United Arab EmiratesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07520032, who can take part
Where in United Arab Emirates
- Gulf Medical UniversityAjman, United Arab EmiratesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Gulf Medical University
- Trial code
- NCT07520032
- Record updated
- 24 September 2026
- Original description
Stroke is a leading cause of death and disability worldwide. A major complication of stroke is spasticity, marked by increased muscle tone and impaired movement. It affects majority stroke patients and complicates rehabilitation, affecting the upper limb function of survivors.Read full original descriptionShow less
Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke: Randomized Controlled Trial.
Stroke is a leading cause of death and disability worldwide. A major complication of stroke is spasticity, marked by increased muscle tone and impaired movement. It affects majority stroke patients and complicates rehabilitation, affecting the upper limb function of survivors.
While traditional treatments like oral medications and botulinum toxin injections offer some relief, they have notable limitations, causing the need for novel, non-invasive approaches. Extracorporeal shock wave therapy (ESWT), which uses acoustic waves for regeneration and neuromodulation, has shown promise in reducing spasticity with minimal side effects, though its precise mechanisms and ideal protocols need further study. Current evidence supports ESWT's efficacy and safety, often matching established treatments, but gaps remain regarding standardized application and long-term functional outcomes, highlighting the need for more robust research.
Inclusion: Diagnosed as 1st stroke incidence 6 months back; Both male and female; Age 25 to 65 years; the ability to follow verbal instructions; Modified Ashworth Scale score 1-4.
Exclusion: Recurrent stroke; malignant tumor, pacemakers, infection; Severe contractures or deformities of upper extremity; Chronic pain affecting upper extremity function.